ACE Inhibitors News and Research

RSS
ACE inhibitors act to reduce hypertension by interfering with the conversion of angiotensin I to artery-constricting angiotensin II. Blocking the production of angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. ACE inhibitors currently are recommended as first-line therapy for hypertension in certain patient populations, because of their safety and efficacy.
Study finds ACE inhibitors linked to increased risk of recurrence in women who have had breast cancer

Study finds ACE inhibitors linked to increased risk of recurrence in women who have had breast cancer

America’s best loved drugs: Report

America’s best loved drugs: Report

Cardioxyl's CXL-1020 preclinical data against heart failure presented at ACC meeting

Cardioxyl's CXL-1020 preclinical data against heart failure presented at ACC meeting

Singing reduces blood pressure prior to total knee replacement surgery

Singing reduces blood pressure prior to total knee replacement surgery

Multivitamin supplements can optimize body's metabolic performance

Multivitamin supplements can optimize body's metabolic performance

Study to measure lower pressure's impact on kidney disease, cognitive function

Study to measure lower pressure's impact on kidney disease, cognitive function

WHO concerned about radiation levels in food near damaged Japanese nuclear plant

WHO concerned about radiation levels in food near damaged Japanese nuclear plant

ACE, ARB combination therapy may increase risk of kidney failure, death

ACE, ARB combination therapy may increase risk of kidney failure, death

High blood pressure medications useful even in those without hypertension: Study

High blood pressure medications useful even in those without hypertension: Study

How cocoa in chocolate reduces risk of heart disease

How cocoa in chocolate reduces risk of heart disease

Researchers find kidney-specific gene defects may increase risk of heart failure

Researchers find kidney-specific gene defects may increase risk of heart failure

Metabolon announces publication of 'Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy'

Metabolon announces publication of 'Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy'

AHA recognizes UC Irvine Medical Center's commitment to high-quality cardiac care

AHA recognizes UC Irvine Medical Center's commitment to high-quality cardiac care

Diuretic lessens risk of death from mild heart failure: Study

Diuretic lessens risk of death from mild heart failure: Study

Dialysis patients at elevated risk for sudden cardiac death: Study

Dialysis patients at elevated risk for sudden cardiac death: Study

NCKU develops novel stem cell therapy for heart repair

NCKU develops novel stem cell therapy for heart repair

Study reveals fine-tuning mechanism of angiotensinogen in pre-eclampsia

Study reveals fine-tuning mechanism of angiotensinogen in pre-eclampsia

Research findings likely to have significant implications for treatment of pre-eclampsia, hypertension

Research findings likely to have significant implications for treatment of pre-eclampsia, hypertension

DecImmune Therapeutics receives funds to improve ischemia reperfusion injury outcomes

DecImmune Therapeutics receives funds to improve ischemia reperfusion injury outcomes

Researchers investigate performance levels of resident and staff physicians

Researchers investigate performance levels of resident and staff physicians

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.